Meijer Medicated Foot Powder

Description

Meijer Medicated Foot Powder is a topical formulation designed for the management of foot-related conditions. This product is presented in a 10 oz container. The effective time for this formulation is set for July 1, 2024.

Uses and Indications

This drug is indicated for the temporary relief of pain and itch associated with minor cuts, scrapes, sunburn, insect bites, prickly heat, rashes, minor burns, and minor skin irritation. Additionally, it is effective in drying the oozing of poison ivy, oak, and sumac.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older are instructed to apply the medication freely up to 3 or 4 times daily. For children under 2 years of age, it is recommended to consult a physician prior to use.

For optimal results, it is essential to ensure that the skin is thoroughly dried before application. This preparation step may enhance the effectiveness of the treatment.

Contraindications

Use of this product is contraindicated in the following situations:

Contact with the eyes should be strictly avoided due to the potential for irritation or injury. Additionally, the product is not intended for use in the genital area, as this may lead to adverse effects.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes and to refrain from applying the product to the genital area.

Healthcare professionals should advise patients to discontinue use and seek medical consultation if any of the following occur: the condition worsens, there is persistent or increasing redness, irritation, swelling, or pain, or if symptoms do not improve within 7 days. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought.

In the event of accidental ingestion, immediate medical assistance is required. Patients should be instructed to contact a Poison Control Center at 1-800-222-1222 without delay.

It is essential to keep this product out of the reach of children to prevent accidental exposure or ingestion.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes and the genital area.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, persistence or increase of redness, irritation, swelling, or pain, or if symptoms do not improve within 7 days or clear up only to recur within a few days.

In the event of accidental ingestion, it is crucial for patients to seek medical assistance immediately or contact a Poison Control Center at 1-800-222-1222.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Meijer Medicated Foot Powder (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician prior to use. For children aged 2 years and older, the product may be applied freely up to 3 or 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Meijer Medicated Foot Powder. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not known. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential.

Management of overdosage should be guided by the specific clinical scenario and may include supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise.

In all cases of suspected overdosage, it is vital to gather as much information as possible regarding the substance, amount ingested, and the time of ingestion to facilitate appropriate medical intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of accidental ingestion, patients should be instructed to seek medical help immediately or contact a Poison Control Center at 1-800-222-1222.

Patients should be informed to discontinue use and consult a doctor if their condition worsens. Additionally, they should be advised to stop using the product and seek medical advice if they experience persistent or increasing redness, irritation, swelling, or pain. If symptoms do not improve within 7 days, or if they clear up and then recur within a few days, patients should also be encouraged to consult a healthcare professional.

It is important to remind patients to avoid contact with their eyes while using this product. Furthermore, they should be informed that this product is not intended for use in the genital area.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat, to ensure optimal stability and efficacy. Additionally, it is important to keep the product out of reach of children. Once opened, the product should be discarded to prevent any potential safety concerns.

Additional Clinical Information

The medication is administered topically. For adults and children aged 2 years and older, it should be applied freely up to 3 or 4 times daily. For children under 2 years of age, consultation with a physician is recommended prior to use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Meijer Medicated Foot Powder, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)